Next Article in Journal
Consensus Statement: The 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5–6, 2014
Previous Article in Journal
A Population-Based Study of Ethnicity and Breast Cancer Stage at Diagnosis in Ontario
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 22
Issue 2
10.3747/co.22.2058
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Guidelines on the Use of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Surface Malignancy Arising from Colorectal or Appendiceal Neoplasms

by
P. Dubé
1,2,
L. Sideris
1,2,
C. Law
3,4,
L. Mack
5,
E. Haase
6,
C. Giacomantonio
7,
A. Govindarajan
3,8,
M.K. Krzyzanowska
9,
P. Major
10,
Y. McConnell
11,
W. Temple
5,
R. Younan
1,12,
J.A. McCart
3,8,* and
Canadian HIPEC Collaborative Group
1
Department of Surgery, University of Montreal, Montreal, QC, Canada
2
Department of Surgery, Hôpital Maisonneuve–Rosemont, Montreal, QC, Canada
3
Department of Surgery, University of Toronto, Toronto, ON, Canada
4
Department of Surgery, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
5
Department of Surgery, University of Calgary, Calgary, AB, Canada
6
Department of Surgery, University of Alberta, Edmonton, AB, Canada
7
Department of Surgery, Dalhousie University, Halifax, NS, Canada
8
Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada
9
Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
10
Department of Medical Oncology and Hematology, Juravinski Cancer Centre, Hamilton, ON, Canada
11
Department of Surgery, University of British Columbia, Vancouver, BC, Canada
12
Department of Surgery, Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2015, 22(2), 100-112; https://doi.org/10.3747/co.22.2058
Submission received: 6 January 2015 / Revised: 2 February 2015 / Accepted: 6 March 2015 / Published: 5 April 2015

Abstract

To meet the needs of patients, Canadian surgical and medical oncology leaders in the treatment of peritoneal surface malignancies (PSMS), together with patient representatives, formed the Canadian HIPEC Collaborative Group (CHICG). The group is dedicated to standardizing and improving the treatment of PSM in Canada so that access to treatment and, ultimately, the prognosis of Canadian patients with PSM are improved. Patients with resectable PSM arising from colorectal or appendiceal neoplasms should be reviewed by a multidisciplinary team including surgeons and medical oncologists with experience in treating patients with PSM. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy should be offered to appropriately selected patients and performed at experienced centres. The aim of this publication is to present guidelines that we recommend be applied across the country for the treatment of PSM.
Keywords: peritoneal surface malignancy; pseudomyxoma peritonei; carcinomatosis; colorectal cancer; appendiceal cancer; hyperthermic intraperitoneal chemotherapy; cytoreductive surgery; peritoneal metastasis peritoneal surface malignancy; pseudomyxoma peritonei; carcinomatosis; colorectal cancer; appendiceal cancer; hyperthermic intraperitoneal chemotherapy; cytoreductive surgery; peritoneal metastasis

Share and Cite

MDPI and ACS Style

Dubé, P.; Sideris, L.; Law, C.; Mack, L.; Haase, E.; Giacomantonio, C.; Govindarajan, A.; Krzyzanowska, M.K.; Major, P.; McConnell, Y.; et al. Guidelines on the Use of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Surface Malignancy Arising from Colorectal or Appendiceal Neoplasms. Curr. Oncol. 2015, 22, 100-112. https://doi.org/10.3747/co.22.2058

AMA Style

Dubé P, Sideris L, Law C, Mack L, Haase E, Giacomantonio C, Govindarajan A, Krzyzanowska MK, Major P, McConnell Y, et al. Guidelines on the Use of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Surface Malignancy Arising from Colorectal or Appendiceal Neoplasms. Current Oncology. 2015; 22(2):100-112. https://doi.org/10.3747/co.22.2058

Chicago/Turabian Style

Dubé, P., L. Sideris, C. Law, L. Mack, E. Haase, C. Giacomantonio, A. Govindarajan, M.K. Krzyzanowska, P. Major, Y. McConnell, and et al. 2015. "Guidelines on the Use of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Surface Malignancy Arising from Colorectal or Appendiceal Neoplasms" Current Oncology 22, no. 2: 100-112. https://doi.org/10.3747/co.22.2058

Article Metrics

Back to TopTop